**Abstract**

The clinical strategy for treatment-resistant depression which includes overlap between bipolar disorder remains inadequate. Establishment of a diagnostic method and understanding of the detailed pathogenesis of those patients are urgently needed.

In this study, we performed comparative analysis of depressive-like behaviors and variations of depression-related molecules in the brain and peripheral blood between controls and refractory depression model animals established by the combined stress of fetal period alcohol and adolescent chronic corticosterone (CORT) treatment. With a part of this model animal, we have also administered antidepressants (SSSRI) for the purpose of investigation of possible treatment method and molecular pathogenesis in refractory type of depression. Focusing on the report of region specific BDNF activity in the pathogenesis of refractory depression, we have compared BDNF levels in frontal cortex, hippocampus, and amygdala in each group of animals. In addition, we have measured BDNF and BDNF expression related microRNA (miRNA206) contents in all exosome and brain-derived exosome in the peripheral blood, aimed at the identification of peripheral molecular dynamics that specifically reflect the changes in the brain. All experiments have carried out according to the approval of the Sapporo Medical University Animal Care and Use Committee with consideration so as not to give unnecessary pain to the animal.

We have found that blood BDNF levels of refractory depression (7.4 ng/ml ± 1.50) showed significantly higher (p\<0.05) than the controls (5.6 ng/ml ± 1.02) and simple depression models (4.5 ng/ml ± 0.84), and antidepressant tended to increase the BDNF levels in depression model (6.2 ng/ml ± 1.54), but reduced in refractory depression models (5.6 ng/ml ± 1.38). Furthermore, interestingly, the variation of blood BDNF levels and the way of the changes in the exosome is different. In considering the clinical report that indicated higher levels of blood BDNF in the non-reactive group of antidepressant treatment prior to administration, we are continuing analysis to identify the pathological mechanism that is common to the intractable depression.
